Experiment ID: 1231

Field Description
namegut-microbiota-based ensemble model predicts prognosis of pediatric inflammatory bowel disease (11650326) - gpt-5-mini
proj_id11650326
sraprjna917086
date_of_upload15/10/2025 21:08
doi10.1016/j.isci.2024.111442
modelgpt-5-mini

Annotations for experiment:

term enrichment score
TermScore
active disease0.418605
LOWER IN active disease0.242424
adolescent stage0.142857
irritable bowel syndrome0.139535
south korea0.100000
ileum0.095588
LOWER IN ileum0.094118
ulcerative colitis0.083601
colon0.082474
crohn's disease0.080247
LOWER IN crohn's disease0.076190
LOWER IN colon0.075949
LOWER IN ulcerative colitis0.073394
LOWER IN irritable bowel syndrome0.064516
LOWER IN control0.008759
control0.008696
homo sapiens0.005168
feces0.004577
Fraction of dbbact annotations with this term covered by the query
TermScore
active disease0.500000
LOWER IN active disease0.500000
LOWER IN irritable bowel syndrome0.166667
irritable bowel syndrome0.166667
adolescent stage0.076923
LOWER IN ileum0.066667
LOWER IN colon0.055556
ileum0.052632
south korea0.052632
LOWER IN crohn's disease0.050000
LOWER IN ulcerative colitis0.047619
ulcerative colitis0.045455
colon0.043478
crohn's disease0.043478
LOWER IN control0.004545
control0.004444
homo sapiens0.002591
feces0.002294
Exp. ID User ID Description Date Region Sequences Status Flag
1231naActive IBD (CD-act + UC-act) vs IBD in remission (CD-rem + UC-rem) ( high in active disease new-onset or recurrent active ibd compared to mucosal remission clinical remission in feces homo sapiens colon ileum crohn's disease ulcerative colitis south korea adolescent stage )2025-10-15v31 / 3pendingNo
1231naActive IBD (CD-act + UC-act) vs IBD in remission (CD-rem + UC-rem) ( high in mucosal remission clinical remission compared to active disease new-onset or recurrent active ibd in feces homo sapiens colon ileum crohn's disease ulcerative colitis south korea adolescent stage )2025-10-15v31 / 3pendingNo
1231naAnti-TNF treated patients vs active IBD (to assess treatment-associated microbiome shifts) ( high in active disease new-onset or recurrent active ibd compared to received anti-tumor necrosis factor alpha therapy anti-tnf-alpha in feces homo sapiens colon ileum crohn's disease ulcerative colitis south korea adolescent stage )2025-10-15v31 / 3pendingNo
1231naActive Ulcerative Colitis (UC-act) (dominant feces, homo sapiens, colon, ulcerative colitis, south korea, active disease, adolescent stage, new-onset or recurrent active ibd)2025-10-15v31 / 16pendingNo
1231naFunctional gastrointestinal disorder (FGID) / FGD (feces) (dominant feces, homo sapiens, colon, irritable bowel syndrome, south korea, adolescent stage)2025-10-15v31 / 18pendingNo
1231naHealthy controls (HC / Control fecal samples) (dominant feces, homo sapiens, control, south korea, adolescent stage)2025-10-15v31 / 20pendingNo
1231naUlcerative Colitis in remission (UC-rem) (dominant feces, homo sapiens, colon, ulcerative colitis, south korea, adolescent stage, mucosal remission, clinical remission)2025-10-15v31 / 21pendingNo
1231naPatients who received anti-TNF-alpha (any state) (dominant feces, homo sapiens, colon, ileum, crohn's disease, ulcerative colitis, south korea, adolescent stage, received anti-tumor necrosis factor alpha therapy, anti-tnf-alpha)2025-10-15v31 / 23pendingNo
1231naCrohn’s disease in remission (CD-rem) (dominant feces, homo sapiens, colon, ileum, crohn's disease, south korea, adolescent stage, mucosal remission, clinical remission)2025-10-15v31 / 24pendingNo
1231naActive Crohn’s disease (CD-act) (common feces, homo sapiens, colon, ileum, crohn's disease, south korea, active disease, adolescent stage, new-onset or recurrent active ibd)2025-10-15v31 / 28pendingNo
1231naActive Crohn’s disease (CD-act) (dominant feces, homo sapiens, colon, ileum, crohn's disease, south korea, active disease, adolescent stage, new-onset or recurrent active ibd)2025-10-15v31 / 28pendingNo
1231naCrohn’s disease in remission (CD-rem) (common feces, homo sapiens, colon, ileum, crohn's disease, south korea, adolescent stage, mucosal remission, clinical remission)2025-10-15v31 / 32pendingNo
1231naPatients who received anti-TNF-alpha (any state) (common feces, homo sapiens, colon, ileum, crohn's disease, ulcerative colitis, south korea, adolescent stage, received anti-tumor necrosis factor alpha therapy, anti-tnf-alpha)2025-10-15v31 / 32pendingNo
1231naActive Ulcerative Colitis (UC-act) (common feces, homo sapiens, colon, ulcerative colitis, south korea, active disease, adolescent stage, new-onset or recurrent active ibd)2025-10-15v31 / 33pendingNo
1231naUlcerative Colitis in remission (UC-rem) (common feces, homo sapiens, colon, ulcerative colitis, south korea, adolescent stage, mucosal remission, clinical remission)2025-10-15v31 / 47pendingNo
1231naFunctional gastrointestinal disorder (FGID) / FGD (feces) (common feces, homo sapiens, colon, irritable bowel syndrome, south korea, adolescent stage)2025-10-15v31 / 51pendingNo
1231naIBD (all states) vs Functional gastrointestinal disorder (FGID) ( high in irritable bowel syndrome compared to ileum crohn's disease ulcerative colitis active disease new-onset or recurrent active ibd mucosal remission clinical remission in feces homo sapiens colon south korea adolescent stage )2025-10-15v31 / 56pendingNo
1231naIBD (all states) vs Functional gastrointestinal disorder (FGID) ( high in ileum crohn's disease ulcerative colitis active disease new-onset or recurrent active ibd mucosal remission clinical remission compared to irritable bowel syndrome in feces homo sapiens colon south korea adolescent stage )2025-10-15v31 / 57pendingNo
1231naHealthy controls (HC / Control fecal samples) (common feces, homo sapiens, control, south korea, adolescent stage)2025-10-15v31 / 61pendingNo
1231naPatients who received anti-TNF-alpha vs Healthy controls ( high in control compared to colon ileum crohn's disease ulcerative colitis received anti-tumor necrosis factor alpha therapy anti-tnf-alpha in feces homo sapiens south korea adolescent stage )2025-10-15v31 / 72pendingNo
1231naPatients who received anti-TNF-alpha vs Healthy controls ( high in colon ileum crohn's disease ulcerative colitis received anti-tumor necrosis factor alpha therapy anti-tnf-alpha compared to control in feces homo sapiens south korea adolescent stage )2025-10-15v31 / 75pendingNo
1231naActive IBD (CD-act + UC-act) vs Healthy controls ( high in colon ileum crohn's disease ulcerative colitis active disease new-onset or recurrent active ibd compared to control in feces homo sapiens south korea adolescent stage )2025-10-15v31 / 94pendingNo
1231naActive IBD (CD-act + UC-act) vs Healthy controls ( high in control compared to colon ileum crohn's disease ulcerative colitis active disease new-onset or recurrent active ibd in feces homo sapiens south korea adolescent stage )2025-10-15v31 / 97pendingNo
1231naAll IBD (CD-act + CD-rem + UC-act + UC-rem) vs Healthy controls ( high in control compared to colon ileum crohn's disease ulcerative colitis active disease new-onset or recurrent active ibd mucosal remission clinical remission in feces homo sapiens south korea adolescent stage )2025-10-15v31 / 113pendingNo
1231naAll IBD (CD-act + CD-rem + UC-act + UC-rem) vs Healthy controls ( high in colon ileum crohn's disease ulcerative colitis active disease new-onset or recurrent active ibd mucosal remission clinical remission compared to control in feces homo sapiens south korea adolescent stage )2025-10-15v31 / 116pendingNo

Problems / suggestions? Please visit the dbBact forum